FB2024_03 , released June 25, 2024
Reference Report
Open Close
Reference
Citation
Bazzi, W., Monticelli, S., Delaporte, C., Riet, C., Giangrande, A., Cattenoz, P.B. (2023). Gcm counteracts Toll-induced inflammation and impacts hemocyte number through cholinergic signaling.  Front. Immunol. 14(): 1293766.
FlyBase ID
FBrf0258208
Publication Type
Research paper
Abstract
Hemocytes, the myeloid-like immune cells of Drosophila, fulfill a variety of functions that are not completely understood, ranging from phagocytosis to transduction of inflammatory signals. We here show that downregulating the hemocyte-specific Glial cell deficient/Glial cell missing (Glide/Gcm) transcription factor enhances the inflammatory response to the constitutive activation of the Toll pathway. This correlates with lower levels of glutathione S-transferase, suggesting an implication of Glide/Gcm in reactive oxygen species (ROS) signaling and calling for a widespread anti-inflammatory potential of Glide/Gcm. In addition, our data reveal the expression of acetylcholine receptors in hemocytes and that Toll activation affects their expressions, disclosing a novel aspect of the inflammatory response mediated by neurotransmitters. Finally, we provide evidence for acetylcholine receptor nicotinic acetylcholine receptor alpha 6 (nAchRalpha6) regulating hemocyte proliferation in a cell autonomous fashion and for non-cell autonomous cholinergic signaling regulating the number of hemocytes. Altogether, this study provides new insights on the molecular pathways involved in the inflammatory response.
PubMed ID
PubMed Central ID
PMC10684909 (PMC) (EuropePMC)
Associated Information
Comments
Associated Files
Other Information
Secondary IDs
    Language of Publication
    English
    Additional Languages of Abstract
    Parent Publication
    Publication Type
    Journal
    Abbreviation
    Front. Immunol.
    Title
    Frontiers in immunology
    ISBN/ISSN
    1664-3224
    Data From Reference